-
1
-
-
84866268783
-
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
-
Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364-1379.
-
(2012)
Diabetes Care
, vol.35
, pp. 1364-1379
-
-
Inzucchi, S.E.1
Bergenstal, R.M.2
Buse, J.B.3
-
2
-
-
64749100501
-
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
-
Nathan DM, Buse JB, Davidson MB et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009; 32: 193-203.
-
(2009)
Diabetes Care
, vol.32
, pp. 193-203
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
-
3
-
-
79955752170
-
Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations
-
Bennett WL, Maruthur NM, Singh S et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med 2011; 154: 602-613.
-
(2011)
Ann Intern Med
, vol.154
, pp. 602-613
-
-
Bennett, W.L.1
Maruthur, N.M.2
Singh, S.3
-
4
-
-
77950891085
-
Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes
-
Phung OJ, Scholle JM, Talwar M, Coleman CI. Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA 2010; 303: 1410-1418.
-
(2010)
JAMA
, vol.303
, pp. 1410-1418
-
-
Phung, O.J.1
Scholle, J.M.2
Talwar, M.3
Coleman, C.I.4
-
5
-
-
45149131667
-
Effects of intensive glucose lowering in type 2 diabetes
-
Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
-
(2008)
N Engl J Med
, vol.358
, pp. 2545-2559
-
-
Gerstein, H.C.1
Miller, M.E.2
-
6
-
-
58149389215
-
Glucose control and vascular complications in veterans with type 2 diabetes
-
Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139.
-
(2009)
N Engl J Med
, vol.360
, pp. 129-139
-
-
Duckworth, W.1
Abraira, C.2
Moritz, T.3
-
7
-
-
45149133036
-
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
-
ADVANCE Collaborative Group, Patel A, MacMahon S et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
-
(2008)
N Engl J Med
, vol.358
, pp. 2560-2572
-
-
Patel, A.1
MacMahon, S.2
-
8
-
-
84905740655
-
A meta-analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes
-
Monami M, Dicembrini I, Kundisova L, Zannoni S, Nreu B, Mannucci E. A meta-analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes. Diabetes Obes Metab 2014; 16: 833-840.
-
(2014)
Diabetes Obes Metab
, vol.16
, pp. 833-840
-
-
Monami, M.1
Dicembrini, I.2
Kundisova, L.3
Zannoni, S.4
Nreu, B.5
Mannucci, E.6
-
9
-
-
84876796916
-
Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society
-
Seaquist ER, Anderson J, Childs B et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013; 36: 1384-1395.
-
(2013)
Diabetes Care
, vol.36
, pp. 1384-1395
-
-
Seaquist, E.R.1
Anderson, J.2
Childs, B.3
-
10
-
-
74949117631
-
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
-
Bonds DE, Miller ME, Bergenstal RM et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010; 340: b4909.
-
(2010)
BMJ
, vol.340
, pp. b4909
-
-
Bonds, D.E.1
Miller, M.E.2
Bergenstal, R.M.3
-
11
-
-
84881416448
-
Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis
-
Goto A, Arah OA, Goto M, Terauchi Y, Noda M. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis. BMJ 2013; 347: f4533.
-
(2013)
BMJ
, vol.347
, pp. f4533
-
-
Goto, A.1
Arah, O.A.2
Goto, M.3
Terauchi, Y.4
Noda, M.5
-
12
-
-
77957742069
-
Severe hypoglycemia and risks of vascular events and death
-
Zoungas S, Patel A, Chalmers J et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010; 363: 1410-1418.
-
(2010)
N Engl J Med
, vol.363
, pp. 1410-1418
-
-
Zoungas, S.1
Patel, A.2
Chalmers, J.3
-
13
-
-
84862108594
-
Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes
-
Zhao Y, Campbell CR, Fonseca V, Shi L. Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes. Diabetes Care 2012; 35: 1126-1132.
-
(2012)
Diabetes Care
, vol.35
, pp. 1126-1132
-
-
Zhao, Y.1
Campbell, C.R.2
Fonseca, V.3
Shi, L.4
-
14
-
-
0043170900
-
Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring
-
Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care 2003; 26: 1485-1489.
-
(2003)
Diabetes Care
, vol.26
, pp. 1485-1489
-
-
Desouza, C.1
Salazar, H.2
Cheong, B.3
Murgo, J.4
Fonseca, V.5
-
15
-
-
43449100355
-
Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study
-
Alvarez Guisasola F, Tofé Povedano S, Krishnarajah G, Lyu R, Mavros P, Yin D. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab 2008; 10(Suppl. 1): 25-32.
-
(2008)
Diabetes Obes Metab
, vol.10
, pp. 25-32
-
-
Alvarez Guisasola, F.1
Tofé Povedano, S.2
Krishnarajah, G.3
Lyu, R.4
Mavros, P.5
Yin, D.6
-
16
-
-
84861109293
-
Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea
-
Lund A, Knop FK. Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea. Curr Med Res Opin 2012; 28: 731-736.
-
(2012)
Curr Med Res Opin
, vol.28
, pp. 731-736
-
-
Lund, A.1
Knop, F.K.2
-
17
-
-
74849099588
-
Patient-reported tolerability issues with oral antidiabetic agents: associations with adherence; treatment satisfaction and health-related quality of life
-
Pollack MF, Purayidathil FW, Bolge SC, Williams SA. Patient-reported tolerability issues with oral antidiabetic agents: associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Res Clin Pract 2010; 87: 204-210.
-
(2010)
Diabetes Res Clin Pract
, vol.87
, pp. 204-210
-
-
Pollack, M.F.1
Purayidathil, F.W.2
Bolge, S.C.3
Williams, S.A.4
-
18
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
19
-
-
84882276623
-
AACE comprehensive diabetes management algorithm 2013
-
Garber AJ, Abrahamson MJ, Barzilay JI et al. AACE comprehensive diabetes management algorithm 2013. Endocr Pract 2013; 19: 327-336.
-
(2013)
Endocr Pract
, vol.19
, pp. 327-336
-
-
Garber, A.J.1
Abrahamson, M.J.2
Barzilay, J.I.3
-
20
-
-
78851472527
-
Effect of linagliptin monotherapy on glycaemic control and markers of beta-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial
-
Del Prato S, Barnett AH, Huisman H, Neubacher D, Woerle HJ, Dugi KA. Effect of linagliptin monotherapy on glycaemic control and markers of beta-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial. Diabetes Obes Metab 2011; 13: 258-267.
-
(2011)
Diabetes Obes Metab
, vol.13
, pp. 258-267
-
-
Del Prato, S.1
Barnett, A.H.2
Huisman, H.3
Neubacher, D.4
Woerle, H.J.5
Dugi, K.A.6
-
21
-
-
78649691630
-
Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
-
Taskinen MR, Rosenstock J, Tamminen I et al. Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Diabetes Obes Metab 2011; 13: 65-74.
-
(2011)
Diabetes Obes Metab
, vol.13
, pp. 65-74
-
-
Taskinen, M.R.1
Rosenstock, J.2
Tamminen, I.3
-
22
-
-
79953174825
-
Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study
-
Gomis R, Espadero RM, Jones R, Woerle HJ, Dugi KA. Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study. Diabetes Obes Metab 2011; 13: 653-661.
-
(2011)
Diabetes Obes Metab
, vol.13
, pp. 653-661
-
-
Gomis, R.1
Espadero, R.M.2
Jones, R.3
Woerle, H.J.4
Dugi, K.A.5
-
23
-
-
80053072352
-
Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study
-
Owens DR, Swallow R, Dugi KA, Woerle HJ. Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study. Diabet Med 2011; 28: 1352-1361.
-
(2011)
Diabet Med
, vol.28
, pp. 1352-1361
-
-
Owens, D.R.1
Swallow, R.2
Dugi, K.A.3
Woerle, H.J.4
-
24
-
-
84864757433
-
2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial
-
Gallwitz B, Rosenstock J, Rauch T et al. 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial. Lancet 2012; 380: 475-483.
-
(2012)
Lancet
, vol.380
, pp. 475-483
-
-
Gallwitz, B.1
Rosenstock, J.2
Rauch, T.3
-
25
-
-
84875550847
-
Linagliptin is more effective than glimepiride at achieving a composite outcome of target HbA(1)c<7% with no hypoglycaemia and no weight gain over 2 years
-
Gallwitz B, Rosenstock J, Emser A, von Eynatten M, Woerle HJ. Linagliptin is more effective than glimepiride at achieving a composite outcome of target HbA(1)c<7% with no hypoglycaemia and no weight gain over 2 years. Int J Clin Pract 2013; 67: 317-321.
-
(2013)
Int J Clin Pract
, vol.67
, pp. 317-321
-
-
Gallwitz, B.1
Rosenstock, J.2
Emser, A.3
von Eynatten, M.4
Woerle, H.J.5
-
26
-
-
18144388647
-
Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia
-
Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 28: 1245-1249.
-
(2005)
Diabetes Care
, vol.28
, pp. 1245-1249
-
-
-
27
-
-
0028608981
-
Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM
-
Dagogo-Jack S, Rattarasarn C, Cryer PE. Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM. Diabetes 1994; 43: 1426-1434.
-
(1994)
Diabetes
, vol.43
, pp. 1426-1434
-
-
Dagogo-Jack, S.1
Rattarasarn, C.2
Cryer, P.E.3
-
28
-
-
33644817974
-
Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities
-
Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care 2005; 28: 2948-2961.
-
(2005)
Diabetes Care
, vol.28
, pp. 2948-2961
-
-
Zammitt, N.N.1
Frier, B.M.2
-
29
-
-
84862068178
-
Substantial increase in incidence of severe hypoglycemia between 1997-2000 and 2007-2010: a German longitudinal population-based study
-
Holstein A, Patzer OM, Machalke K, Holstein JD, Stumvoll M, Kovacs P. Substantial increase in incidence of severe hypoglycemia between 1997-2000 and 2007-2010: a German longitudinal population-based study. Diabetes Care 2012; 35: 972-975.
-
(2012)
Diabetes Care
, vol.35
, pp. 972-975
-
-
Holstein, A.1
Patzer, O.M.2
Machalke, K.3
Holstein, J.D.4
Stumvoll, M.5
Kovacs, P.6
-
30
-
-
84904128236
-
National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011
-
Lipska KJ, Ross JS, Wang Y et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med 2014; 174: 1116-1124.
-
(2014)
JAMA Intern Med
, vol.174
, pp. 1116-1124
-
-
Lipska, K.J.1
Ross, J.S.2
Wang, Y.3
-
31
-
-
84897868393
-
Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012
-
Turner LW, Nartey D, Stafford RS, Singh S, Alexander GC. Ambulatory treatment of type 2 diabetes in the U.S., 1997-2012. Diabetes Care 2014; 37: 985-992.
-
(2014)
Diabetes Care
, vol.37
, pp. 985-992
-
-
Turner, L.W.1
Nartey, D.2
Stafford, R.S.3
Singh, S.4
Alexander, G.C.5
-
32
-
-
81855169543
-
Emergency hospitalizations for adverse drug events in older Americans
-
Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365: 2002-2012.
-
(2011)
N Engl J Med
, vol.365
, pp. 2002-2012
-
-
Budnitz, D.S.1
Lovegrove, M.C.2
Shehab, N.3
Richards, C.L.4
-
33
-
-
84890876627
-
HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study
-
Lipska KJ, Warton EM, Huang ES et al. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care 2013; 36: 3535-3542.
-
(2013)
Diabetes Care
, vol.36
, pp. 3535-3542
-
-
Lipska, K.J.1
Warton, E.M.2
Huang, E.S.3
-
34
-
-
74949138626
-
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study
-
Miller ME, Bonds DE, Gerstein HC et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2010; 340: b5444.
-
(2010)
BMJ
, vol.340
, pp. b5444
-
-
Miller, M.E.1
Bonds, D.E.2
Gerstein, H.C.3
-
35
-
-
0031955215
-
Glimepiride. A review of its use in the management of type 2 diabetes mellitus
-
Langtry HD, Balfour JA. Glimepiride. A review of its use in the management of type 2 diabetes mellitus. Drugs 1998; 55: 563-584.
-
(1998)
Drugs
, vol.55
, pp. 563-584
-
-
Langtry, H.D.1
Balfour, J.A.2
-
36
-
-
84880919649
-
Effect of sulfonylurea dose escalation on hemoglobin A1c in Veterans Affairs patients with type 2 diabetes
-
Hurren KM, Bartley EP, O'Neill JL, Ronis DL. Effect of sulfonylurea dose escalation on hemoglobin A1c in Veterans Affairs patients with type 2 diabetes. Acta Diabetol 2013; 50: 261-265.
-
(2013)
Acta Diabetol
, vol.50
, pp. 261-265
-
-
Hurren, K.M.1
Bartley, E.P.2
O'Neill, J.L.3
Ronis, D.L.4
-
37
-
-
0029801225
-
A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group
-
Goldberg RB, Holvey SM, Schneider J. A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group. Diabetes Care 1996; 19: 849-856.
-
(1996)
Diabetes Care
, vol.19
, pp. 849-856
-
-
Goldberg, R.B.1
Holvey, S.M.2
Schneider, J.3
-
38
-
-
4344693381
-
GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients
-
Schernthaner G, Grimaldi A, Di Mario U et al. GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest 2004; 34: 535-542.
-
(2004)
Eur J Clin Invest
, vol.34
, pp. 535-542
-
-
Schernthaner, G.1
Grimaldi, A.2
Di Mario, U.3
-
39
-
-
84921433676
-
Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes
-
[Epub ahead of print].
-
Avogaro A, Dardano A, de Kreutzenberg SV, Del Prato S. Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes. Diabetes Obes Metab 2014; DOI: 10.1111/dom.12319. [Epub ahead of print].
-
(2014)
Diabetes Obes Metab
-
-
Avogaro, A.1
Dardano, A.2
de Kreutzenberg, S.V.3
Del Prato, S.4
-
40
-
-
84886297885
-
Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial
-
Barnett AH, Huisman H, Jones R, von Eynatten M, Patel S, Woerle HJ. Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial. Lancet 2013; 382: 1413-1423.
-
(2013)
Lancet
, vol.382
, pp. 1413-1423
-
-
Barnett, A.H.1
Huisman, H.2
Jones, R.3
von Eynatten, M.4
Patel, S.5
Woerle, H.J.6
-
41
-
-
84879399096
-
Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies
-
Forst T, Hanefeld M, Jacob S et al. Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies. Diab Vasc Dis Res 2013; 10: 302-314.
-
(2013)
Diab Vasc Dis Res
, vol.10
, pp. 302-314
-
-
Forst, T.1
Hanefeld, M.2
Jacob, S.3
-
42
-
-
84860117993
-
Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database
-
Tzoulaki I, Molokhia M, Curcin V et al. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ 2009; 339: b4731.
-
(2009)
BMJ
, vol.339
, pp. b4731
-
-
Tzoulaki, I.1
Molokhia, M.2
Curcin, V.3
-
44
-
-
84863309250
-
Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis
-
Deacon CF, Mannucci E, Ahrén B. Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis. Diabetes Obes Metab 2012; 14: 762-767.
-
(2012)
Diabetes Obes Metab
, vol.14
, pp. 762-767
-
-
Deacon, C.F.1
Mannucci, E.2
Ahrén, B.3
-
45
-
-
84862302997
-
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial
-
Gallwitz B, Guzman J, Dotta F et al. Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial. Lancet 2012; 379: 2270-2278.
-
(2012)
Lancet
, vol.379
, pp. 2270-2278
-
-
Gallwitz, B.1
Guzman, J.2
Dotta, F.3
|